Cell Culture Technology– category –
-
REPROCELL Offers High-Quality Clinical-Grade iPSC Services with Proprietary StemRNA™ 3rd Gen Technology, Including Reprogramming, Differentiation, and Gene Editing
REPROCELL Japan Overview REPROCELL provides comprehensive, high-quality iPSC reprogramming, differentiation, and gene editing services utilizing its proprietary StemRNA™ 3rd Gen Reprogramming technology. These services encompass efficien... -
Technology Networks Delineates Commercialization Strategies for iPSC Therapies: Automated Manufacturing and Immune-Evasive Cell Line Development are Key
Technology Networks UK Overview Technology Networks provides an in-depth analysis of strategic challenges and solutions for the commercial viability of iPSC-based therapies, emphasizing the critical importance of scalable manufacturing, ... -
Small-Scale Bioreactors Market Sees Robust Growth Driven by Innovation; Culture Biosciences and Cytiva Bioscience Partnership Advances Automation
openPR.com International Overview This article provides an overview of a market research report introduced by openPR.com, highlighting significant growth in the small-scale bioreactors market, driven by innovations in bioprocessing effic... -
20 Years of iPSCs: From Bespoke Models to Standardized Biologic Medicines, as Reviewed by Nature Biotechnology
Nature Biotechnology / Stem Cell Reports (via Facebook) International Overview Celebrating the 20th anniversary of iPSC discovery, Nature Biotechnology and Stem Cell Reports reviewed the technology's evolution from bespoke experimental m... -
Retinal Diseases Emerge as Key Proving Ground for Next-Gen iPSC Regenerative Therapies, BioProcess International Reports
BioProcess International USA Overview BioProcess International reports that iPSC-derived regenerative therapies are increasingly seen as the primary proving ground for next-generation treatments in retinal diseases. iPSCs enable scalable... -
REPROCELL Accelerates Clinical-Grade iPSC Manufacturing Scale-Up with StemRNA™ Clinical Platform and AI-Driven StemEdit
REPROCELL Japan Overview REPROCELL is significantly accelerating the scale-up of clinical-grade induced pluripotent stem cell (iPSC) manufacturing by leveraging its proprietary StemRNA™ Clinical iPSC platform and AI-driven StemEdit gene-... -
Cell Culture Technology Weekly Report August 30, 2026
▼ ▼ ▼ If the infographic makes you want to read the full report, please click the download button below. ▼ ▼ ▼ 📄 Weekly Report August 30, 2026 (PDF) — Download Weekly Report August 30, 2026 (PDF) — DownloadDownload 🎙 Podcast August 30, ... -
Estonian Innovators ÄIO and TFTAK Secure €1.94M for DigiFoundry 2.0: Scaling Precision Fermentation for Cost-Efficient Microbial Oils
Industry News/Press Release Estonia Overview Estonian biotech ÄIO and applied research institution TFTAK have secured €1.94 million for their DigiFoundry 2.0 program, aiming to dramatically boost the efficiency and industrial scalability... -
ADM Invests $55.5M in Clinton, Iowa Facility to Expand Precision Fermentation Capacity for High-Value Bio-Based Products
Green Queen Media USA Overview ADM has announced a $55.5 million investment to significantly expand its precision fermentation capabilities at its Clinton, Iowa facility, supported by a $2.23 million grant from the Iowa Economic Developm... -
4basebio and Genezen Partner to Revolutionize Viral Vector Manufacturing: hpDNA Boosts AAV Titers by up to 33-fold
AllSci Overview 4basebio and Genezen have announced a strategic collaboration to integrate 4basebio's hpDNA platform into viral vector manufacturing workflows, aiming to significantly enhance efficiency. This innovative cell-free synthet...
